Whole-Body MRI, Clinical Applications Especially in the Assessment of Bone Marrow Diseases

Abstract

This article's goal is to discuss whole-body MRI's current image collection and interpretation methods, clinical uses, and emerging roles in oncologic imaging, particularly in the evaluation of bone marrow disorders. As part of national and international recommendations for imaging patients with myeloma or metastatic prostate cancer, whole-body magnetic resonance imaging (MRI) is now a vital technique for determining the degree of systemic malignant bone disease and the response to treatment. Modern MRI systems from all major manufacturers can now acquire high-quality whole-body MRI data in less than 45 minutes because to recent advances in scanner technology. This offers complementary morphological and functional whole-body imaging, but adoption in busy radiology departments may be hampered by the need for prior knowledge and the length of the acquisition process. Whole-body MRI is a newly developed method used in cancer for early diagnosis, staging, and evaluation of therapy response. The expansion of its use and acceptance in clinical practice has been accelerated by improvements in accessibility and technological advancements, particularly widely accessible sequences (Dixon and DWI).